| Followers | 202 |
| Posts | 25627 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Wednesday, August 28, 2024 7:31:31 AM
You have to read to know what is what and what may be converted and what may not be converted. You had to add things that may not become shared and I don’t have time ti spare for you. But those are not currently all traded, public shares and there is reason to never, ever trust what you post on this subject because of your history.
But yeah, you jump to convert things not yet issued and not necessarily to be issued as shares. They may be, just like authorized shares may become issued shares, but the point of a share count is to count what is public now and traded now. For a buyout, certain other issuances become more relevant IF they are convertible by the holder and are not paid back as cash before the conversion happens. And as I said, with large numbers, it is easy for people such as you to add lots of things together and make any over counting seem minor.
Doing your own come noting and claiming “it’s all in the financials” is a common claim of shorts that frequently turns out to be exaggerated
I don’t “campaign”, but I do oppose the idiocy of shorts. When such raises are denied for pre-commercial companies such as this, it leads to disasters for common shareholders, which is exactly what short hedge funds want.
You’re always destructive, and always under the pretense that “you care”.
But yeah, you jump to convert things not yet issued and not necessarily to be issued as shares. They may be, just like authorized shares may become issued shares, but the point of a share count is to count what is public now and traded now. For a buyout, certain other issuances become more relevant IF they are convertible by the holder and are not paid back as cash before the conversion happens. And as I said, with large numbers, it is easy for people such as you to add lots of things together and make any over counting seem minor.
Doing your own come noting and claiming “it’s all in the financials” is a common claim of shorts that frequently turns out to be exaggerated
I don’t “campaign”, but I do oppose the idiocy of shorts. When such raises are denied for pre-commercial companies such as this, it leads to disasters for common shareholders, which is exactly what short hedge funds want.
You’re always destructive, and always under the pretense that “you care”.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
